[HTML][HTML] Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL …
NM deSouza, E Achten, A Alberich-Bayarri… - Insights into …, 2019 - Springer
Observer-driven pattern recognition is the standard for interpretation of medical images. To
achieve global parity in interpretation, semi-quantitative scoring systems have been …
achieve global parity in interpretation, semi-quantitative scoring systems have been …
[HTML][HTML] Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update
K Kitajima, M Nakajo, H Kaida… - Nagoya journal of …, 2017 - ncbi.nlm.nih.gov
Positron emission tomography/computed tomography (PET/CT) integrated with 2-[18 F]
fluoro-2-deoxy-D-glucose (FDG) is a useful tool for acquisition of both glucose metabolism …
fluoro-2-deoxy-D-glucose (FDG) is a useful tool for acquisition of both glucose metabolism …
Role of imaging in esophageal cancer management in 2020: update for radiologists
VS Jayaprakasam, R Yeh, GY Ku… - American Journal of …, 2020 - Am Roentgen Ray Soc
OBJECTIVE. The purpose of this article is to discuss the role of imaging in the management
of esophageal cancer. CONCLUSION. A multimodality-based approach to imaging is …
of esophageal cancer. CONCLUSION. A multimodality-based approach to imaging is …
[HTML][HTML] Prognosis and treatment after diagnosis of recurrent esophageal carcinoma following esophagectomy with curative intent
K Parry, E Visser, PSN van Rossum… - Annals of surgical …, 2015 - Springer
Background Strategies for the treatment of recurrence after initial curative esophagectomy
are increasingly being recognized. The aim of this study was to identify prognostic factors …
are increasingly being recognized. The aim of this study was to identify prognostic factors …
Variants and pitfalls in PET/CT imaging of gastrointestinal cancers
VS Jayaprakasam, V Paroder, H Schöder - Seminars in nuclear medicine, 2021 - Elsevier
In the past two decades, PET/CT has become an essential modality in oncology increasingly
used in the management of gastrointestinal (GI) cancers. Most PET/CT tracers used in …
used in the management of gastrointestinal (GI) cancers. Most PET/CT tracers used in …
Accuracy of 18F-FDG PET/CT in predicting residual disease after neoadjuvant chemoradiotherapy for esophageal cancer
MJ Valkema, BJ Noordman… - Journal of Nuclear …, 2019 - Soc Nuclear Med
Our purpose was to prospectively investigate optimal evaluation of qualitative and
quantitative 18F-FDG PET/CT in response evaluations 12–14 wk after neoadjuvant …
quantitative 18F-FDG PET/CT in response evaluations 12–14 wk after neoadjuvant …
Clinical impact of FDG PET/CT in alimentary tract malignancies: an updated review
EA Akin, ZN Qazi, M Osman, RK Zeman - Abdominal Radiology, 2020 - Springer
The use of 18 F-fluorodeoxyglucose (FDG) positron emission tomography combined with
computed tomography (PET/CT) is well established in the evaluation of alimentary tract …
computed tomography (PET/CT) is well established in the evaluation of alimentary tract …
[HTML][HTML] Identification of tumor-specific MRI biomarkers using machine learning (ML)
The identification of reliable and non-invasive oncology biomarkers remains a main priority
in healthcare. There are only a few biomarkers that have been approved as diagnostic for …
in healthcare. There are only a few biomarkers that have been approved as diagnostic for …
[HTML][HTML] The emerging field of radiomics in esophageal cancer: current evidence and future potential
PSN van Rossum, C Xu, DV Fried… - Translational cancer …, 2016 - ncbi.nlm.nih.gov
Abstract 'Radiomics' is the name given to the emerging field of extracting additional
information from standard medical images using advanced feature analysis. This innovative …
information from standard medical images using advanced feature analysis. This innovative …
Management decision based on lymphovascular involvement leads to favorable outcomes after endoscopic treatment of esophageal squamous cell carcinoma
K Takahashi, S Hashimoto, K Mizuno, T Kobayashi… - …, 2018 - thieme-connect.com
Background Esophageal squamous cell carcinoma (ESCC) invading the muscularis
mucosae (MM) and submucosa up to 200 µm (SM1) has a risk of metastasis. The aims of …
mucosae (MM) and submucosa up to 200 µm (SM1) has a risk of metastasis. The aims of …